Journal
BLOOD
Volume 98, Issue 3, Pages 830-833Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.V98.3.830
Keywords
-
Categories
Funding
- NCI NIH HHS [CA76201] Funding Source: Medline
- NIEHS NIH HHS [ES06258] Funding Source: Medline
Ask authors/readers for more resources
Chronic exposure to benzene is associated with hematotoxicity and acute myelogenous leukemia. Inhibition of topoisomerase II alpha (topo 11) has been implicated in the development of benzene-induced cytogenetic aberrations. The purpose of this study was to determine the mechanism of topo 11 inhibition by benzene metabolites. In a DNA cleavage/relaxation assay, topo 11 was inhibited by p-benzoquinone and hydroquinone at 10 muM and 10 muM, respectively. On peroxidase activation, Inhibition was seen with 4,4'-biphenol, hydroquinone, and catechol at 10 muM, 10 muM, and 30 muM, respectively. But, In no case was cleavable complex stabilization observed and the metabolites appeared to act at an earlier step of the enzyme cycle. In support of this conclusion, several metabolites antagonized etoposide-stabilized cleavable complex formation and Inhibited topo R-DNA binding. It is therefore unlikely that benzene-induced acute myelogenous leukemia stems from events Invoked for leukemogenic topo 11 cleavable complex-stabilizing antitumor agents. (C) 2001 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available